Federal contract award
75N93024P01064
GENSCRIPT USA INCORPORATED MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541380 — Testing Laboratories and Services |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $15.0K |
| Current contract value | $15.0K |
| Potential contract value / ceiling | $15.0K |
| Start date | Aug 29, 2024 |
| Current end date | Aug 27, 2025 |
| Potential end date | May 18, 2026 |
| Latest award activity | May 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 21, 2026 | P00001 | $-1.2K | FY 2026 UDO INITIATIVE - THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS. |
| Aug 29, 2024 | 0 | $16.2K | GENSCRIPT USA INCORPORATED MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.